Malaria, including severe malaria

By the end of this study note, the student will be able to recognize, evaluate, risk-stratify, and manage uncomplicated and severe malaria in Kenyan clinical settings; always verify specific drug regimens and clinical pathways against current Kenya Ministry of Health guidelines and institutional formularies.

Definition

Malaria is an acute, potentially life-threatening protozoan infection caused by obligate intra-erythrocytic parasites of the genus Plasmodium, transmitted via the bite of infected female Anopheles mosquitoes.

• Uncomplicated malaria: Symptomatic parasitemia presenting with non-specific constitutional features (fever, chills, headache, arthralgia) in the absence of clinical or laboratory signs of vital organ dysfunction.
• Severe malaria: Infection with asexual forms of Plasmodium falciparum (or rarely P. vivax / P. knowlesi) accompanied by one or more manifestations of acute, severe organ dysfunction, metabolic derangement, or hyperparasitemia.

Anatomy and physiology you need

• Splenic red pulp and microcirculation: The spleen acts as the primary mechanical filter for senescent and rigid red blood cells (RBCs). Endothelial slits in the venous sinusoids require extreme RBC deformability. Normal clearance mechanisms trigger splenic macrophage phagocytosis of parasitized cells, causing reactive splenomegaly.
• Cerebral and systemic microvasculature: Capillaries and post-capillary venules possess endothelial receptors—primarily intercellular adhesion molecule-1 (ICAM-1), endothelial protein C receptor (EPCR), and chondroitin sulfate A (CSA). Parasite-mediated binding to these receptors shields infected cells from splenic filtration while impeding local tissue perfusion.
• Renal tubular architecture: The metabolically active renal tubular epithelium relies on adequate medullary perfusion and microcirculatory oxygen delivery. It is highly susceptible to ischemic acute tubular necrosis triggered by microvascular clogging, intravascular hemolysis (free heme-mediated oxidative damage), and systemic hypovolemia.
• Pulmonary alveolar-capillary barrier: Endothelial activation and systemic inflammatory cascades cause vascular hyperpermeability. In the lung, disruption of this membrane results in non-cardiogenic pulmonary edema (acute respiratory distress syndrome [ARDS]) even without fluid overload.

Causes and risk factors

Etiologic agents in Kenya

• Plasmodium falciparum: Responsible for >95% of infections and virtually all severe disease, complications, and mortality in Kenya.
• Plasmodium malariae: Responsible for indolent quartan malaria; frequently encountered as a co-infection alongside P. falciparum.
• Plasmodium ovale: Endemic in specific low-transmission pockets; maintains dormant liver hypnozoites capable of relapse.
• Plasmodium vivax: Less common overall; increasingly identified in arid northern regions (e.g., Turkana, Garissa) among Duffy-positive populations; possesses hypnozoites.

Transmission dynamics and endemicity zones in Kenya

• Lake endemic zone: Perennial transmission with high seasonal peaks (e.g., Kisumu, Siaya, Busia). Populations develop partial semi-immunity by adulthood; severe disease concentrates in young children and pregnant women.
• Coastal endemic zone: Stable perennial transmission (e.g., Kilifi, Kwale, Mombasa) with variable intensity.
• Highland epidemic-prone zone: Low to unstable transmission (e.g., Kisii, Nandi, Kericho). Populations possess minimal acquired immunity; individuals of all ages are vulnerable to severe disease during outbreaks.
• Semi-arid / Seasonal zones: Sporadic, short transmission seasons following rains (e.g., Kitui, Baringo).
• Low-risk / Arid zones: Negligible transmission (e.g., Nairobi, central highlands); high susceptibility to severe malaria upon travel to endemic areas without prophylaxis.

Host and clinical risk factors

• Age and pregnancy: Children under five years and primigravidae (sequestration of parasites expressing VAR2CSA in placental intervillous vascular beds).
• Advanced HIV infection: Impairs cell-mediated and humoral responses against pre-erythrocytic and erythrocytic stages; linked to higher parasite densities, recurrent treatment failures, and elevated risk of severe malaria.
• Sickle cell disease (HbSS): Susceptible to acute sickle cell crisis precipitated by malarial fever, microcirculatory hypoxia, and rapid functional asplenia. Conversely, sickle cell trait (HbAS) confers protection against severe P. falciparum malaria.
• Severe malnutrition: Blunts pyrexial responses and masks early symptoms, leading to late presentation with profound hypoglycemia and lactic acidosis.
• Tuberculosis co-infection: Chronic systemic inflammation and anemia reduce physiological reserves, compounding metabolic exhaustion and anemic hypoxia during acute attacks.
• Splenectomy or functional asplenia: Eliminates mechanical filtration and splenic clearance of parasitized RBCs, predisposing to explosive parasitemia.

Pathophysiology

Anopheles mosquito inoculation of sporozoites $\rightarrow$ Rapid hepatocyte invasion (silent exo-erythrocytic schizogony) $\rightarrow$ Hepatoschizont rupture releasing thousands of merozoites into bloodstream $\rightarrow$ Merozoite invasion of erythrocytes initiating intra-erythrocytic cycle $\rightarrow$ Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP-1) expressed on RBC membrane knobs $\rightarrow$ Cytoadherence of trophozoite- and schizont-stage RBCs to host endothelial receptors (ICAM-1, EPCR) $\rightarrow$ Sequestration in deep microvasculature (cerebral, renal, intestinal) + rosetting with uninfected RBCs $\rightarrow$ Avoidance of splenic macrophage clearance + severe microvascular obstruction and hypoperfusion $\rightarrow$ Local tissue hypoxia + systemic anaerobic glycolysis $\rightarrow$ Impaired hepatic lactate clearance + type B lactic acidosis (elevated base deficit) $\rightarrow$ Synchronous schizont rupture releasing merozoites, hemozoin, and glycosylphosphatidylinositol (GPI) $\rightarrow$ Toll-like receptor (TLR-2, TLR-4) activation on monocytes and macrophages $\rightarrow$ Massive pro-inflammatory cytokine release (TNF-$\alpha$, IL-1, IL-6, IFN-$\gamma$) $\rightarrow$ Hypothalamic thermoregulatory reset (fever spikes, rigors) + systemic endothelial barrier breakdown $\rightarrow$ Microvascular leakage, dyserythropoiesis, marked intravascular hemolysis, and end-organ failure (cerebral edema, acute tubular necrosis, ARDS).

Clinical features

History

• Fever: Onset, duration, pattern (intermittent, continuous), associated chills and rigors.
• Headache: Location, severity.
• Myalgia/Arthralgia: Generalised body aches.
• Nausea/Vomiting: Frequency, association with meals.
• Abdominal Pain: Location, character, associated bowel changes.
• Diarrhoea: Frequency, consistency, presence of blood.
• Cough/Shortness of Breath: Suggestive of pulmonary involvement.
• Jaundice: Yellowing of skin/eyes.
• Urine Output: Decreased urine output is a critical sign.
• Bleeding: Gum bleeding, epistaxis, haematuria.
• Neurological Symptoms: Confusion, seizures, altered consciousness.
• Travel History: Recent travel to endemic areas.
• Previous Malaria: History of malaria and treatment received.
• Prophylaxis: Use of malaria prophylaxis.
• Co-morbidities: HIV status, TB treatment, sickle cell disease, rheumatic heart disease.

Examination Findings

Differential Diagnosis

Investigations

Diagnosis and Severity

Diagnosis: Clinical suspicion supported by laboratory confirmation (malaria parasite smear or RDT).

Severity Assessment: Based on the presence of any of the following danger signs:

• Impaired Consciousness: Glasgow Coma Scale < 11, or inability to sit up unaided.
• Seizures: Two or more seizures in 24 hours.
• Severe Anaemia: Haemoglobin < 5 g/dL.
• Acute Kidney Injury: Serum creatinine > 3 mg/dL or oliguria (< 400 mL/day in adults).
• Pulmonary Oedema: Radiographic evidence or respiratory rate > 30/min with signs of fluid overload.
• Circulatory Collapse: Shock (systolic BP < 70 mmHg in children, < 80 mmHg in adults) or acidosis.
• Metabolic Acidosis: Bicarbonate < 15 mmol/L or base deficit > 8 mmol/L.
• Hypoglycaemia: Blood glucose < 40 mg/dL.
• Haemoglobinuria: "Blackwater fever".
• Jaundice: Significant jaundice with impaired liver function.
• High Parasitaemia: Peripheral blood parasitaemia > 10% (for P. falciparum).
• Hyperparasitaemia: Peripheral blood parasitaemia > 20% (for P. falciparum).

Management

Immediate stabilisation is paramount in severe malaria. This involves:

• Airway, Breathing, Circulation (ABC): Ensure a patent airway, adequate oxygenation (supplemental oxygen if hypoxic), and circulatory support (intravenous fluids for hypotension).
• Fluid Management: Intravenous fluids are crucial for hypovolemia and shock. Use crystalloids cautiously, monitoring for signs of fluid overload, especially in patients with pulmonary oedema.
• Seizure Control: Administer anticonvulsants if seizures are present.
• Blood Glucose Monitoring: Hypoglycaemia is common in severe malaria, particularly in children. Monitor blood glucose regularly and treat with intravenous glucose if low.

Definitive treatment involves prompt administration of antimalarial drugs.

• Artemisinin-based Combination Therapy (ACT): This is the first-line treatment for uncomplicated Plasmodium falciparum malaria in our setting. ACTs are highly effective and reduce the risk of resistance.
• Intravenous Antimalarials: For severe malaria, parenteral treatment is essential.
  • Artesunate: This is the drug of choice for severe P. falciparum malaria. It should be administered intravenously or intramuscularly.
  • Quinine: Historically used, but artesunate is preferred due to better efficacy and safety profile. It is administered intravenously, often with a continuous infusion.
• Adjunctive Therapies:
  • Blood Transfusion: Indicated for severe anaemia (haemoglobin below a certain threshold, typically <7 g/dL, or lower in symptomatic patients).
  • Renal Replacement Therapy: For established renal failure.
  • Mechanical Ventilation: For respiratory failure.
  • Antipyretics: To manage fever.

Monitoring and Follow-up:

• Vital Signs: Closely monitor temperature, pulse, respiratory rate, blood pressure, and oxygen saturation.
• Neurological Status: Assess level of consciousness, presence of seizures, and focal neurological deficits.
• Fluid Balance: Monitor intake and output to prevent fluid overload.
• Laboratory Parameters: Repeat blood counts, electrolytes, renal function tests, and liver function tests as indicated.
• Parasitaemia: Monitor peripheral blood smears for parasite density to assess response to treatment.
• Follow-up: Patients should be followed up to ensure complete recovery and to screen for potential long-term sequelae.

Contraindications and Safety:

• Artemisinin Derivatives: Generally well-tolerated. Neurotoxicity has been observed in animal studies at high doses, but is rare in humans.
• Quinine: Contraindicated in patients with known hypersensitivity. Can cause cinchonism (tinnitus, headache, nausea, visual disturbances), hypoglycaemia, and cardiac arrhythmias. Careful monitoring is required.
• Intravenous Fluids: Use with caution in patients with pulmonary oedema or cardiac compromise.

Complications and Prognosis

Complications of severe malaria are numerous and can be life-threatening:

The prognosis depends on the severity of illness, promptness of treatment, and presence of complications. Early diagnosis and aggressive management significantly improve outcomes. Untreated or delayed treatment of severe malaria has a high mortality rate.

High-yield Exam Points

• Look-alike conditions: Typhoid fever, bacterial meningitis, severe anaemia from other causes, viral hepatitis.
• Commonest wrong first steps: Delaying antimalarial treatment while awaiting investigations, administering only symptomatic treatment without antimalarials, incorrect fluid management in severe malaria.
• Examiner at bedside:
  • "What is the most likely diagnosis in this patient given their fever and this peripheral blood smear?"
  • "What are the key features that make this case severe malaria?"
  • "How would you manage this patient immediately?"
  • "What are the potential complications we need to watch out for?"
  • "What antimalarial would you choose for this patient and why?"

Clinical Case

A 3-year-old child presents with a three-day history of high fever, lethargy, and poor feeding. On examination, the child is febrile, tachypnoeic, and has a Glasgow Coma Scale of 10/15. They are pale, with a palpable spleen tip. Peripheral blood smear shows numerous Plasmodium falciparum parasites.

Questions:

1. What are the immediate management priorities for this child?
2. What antimalarial treatment would you initiate, and why?
3. What are two potential immediate complications you are concerned about?

Model Answers:

1. Immediate priorities include ABC assessment, oxygenation, intravenous fluid resuscitation for hypovolaemia, blood glucose monitoring and correction if low, and seizure control if present.
2. Intravenous artesunate is the drug of choice for severe P. falciparum malaria due to its rapid action and efficacy.
3. Two potential immediate complications are cerebral malaria (indicated by reduced GCS) and severe anaemia (indicated by pallor).

Practice Questions

Question 1

A 45-year-old man presents with a two-day history of fever, headache, and generalised malaise. He has a palpable spleen. A peripheral blood smear confirms Plasmodium falciparum malaria. His blood pressure is 90/60 mmHg, and he is drowsy but rousable. What is the most appropriate next step in management?

A. Oral artemether-lumefantrine B. Intravenous quinine infusion C. Intravenous artesunate D. Supportive care with antipyretics only

Answer: C. Intravenous artesunate Explanation: The patient's low blood pressure and drowsiness suggest severe malaria, requiring prompt parenteral treatment with intravenous artesunate.

Question 2

Which of the following features would most strongly suggest cerebral malaria over bacterial meningitis in a febrile patient with altered consciousness?

A. Presence of a petechial rash B. Absence of neck stiffness C. High parasite density on peripheral smear D. Rapid response to antibiotics

Answer: C. High parasite density on peripheral smear Explanation: While both can cause altered consciousness, a high parasite density is characteristic of severe malaria, whereas neck stiffness is more typical of meningitis.

Question 3

A 6-year-old child with Plasmodium falciparum malaria is being treated with intravenous artesunate. She develops a haemoglobin of 5 g/dL and is clearly symptomatic. What is the most appropriate additional intervention?

A. Increase the dose of artesunate B. Administer intravenous quinine C. Transfuse with packed red blood cells D. Start oral antimalarials immediately

Answer: C. Transfuse with packed red blood cells Explanation: Severe symptomatic anaemia in the context of malaria requires blood transfusion to improve oxygen-carrying capacity and alleviate symptoms.

Question 4

Which of the following is a common reason for delayed diagnosis of malaria in endemic areas?

A. Over-reliance on rapid diagnostic tests B. Patients presenting with non-specific symptoms C. Availability of effective oral antimalarials D. Low prevalence of Plasmodium falciparum

Answer: B. Patients presenting with non-specific symptoms Explanation: Early malaria symptoms are often non-specific, mimicking other febrile illnesses, leading to delays in seeking appropriate antimalarial treatment.

Question 5

A patient with severe malaria develops acute kidney injury. Which of the following is the most crucial initial management strategy in addition to antimalarial therapy?

A. Aggressive fluid resuscitation with crystalloids B. Initiation of dialysis C. Careful fluid balance and electrolyte monitoring D. Administration of diuretics

Answer: C. Careful fluid balance and electrolyte monitoring Explanation: While fluid management is important, careful monitoring of fluid balance and electrolytes is crucial to avoid fluid overload and manage potential complications of AKI in severe malaria.

Drafted with AI assistance from standard references and reviewed for structure. Check details against your lecture notes and the Kenya MoH guideline.